References
- Feuerborn A, Möritz C, von Bonin F, Dobbelstein M, Trümper L, Stürzenhofecker B, Kube D. Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma. Leuk Lymphoma 2006; 47: 1932–1940
- Roth J, Dittmer D, Rea D, Tartaglia J, Paoletti E, Levine A J. p53 is a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor challenge. Proc Natl Acad Sci USA 1996; 93: 4781–4786
- Phan R T, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432: 635–639